ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Panacea Acquisition Corp

Panacea Acquisition Corp (NUVB)

2.68
-0.01
(-0.37%)
終了 12月22日 6:00AM
2.72
0.04
(1.49%)
取引時間後: 9:49AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
2.72
買値
-
売値
-
出来高
9,242,001
2.57 日の範囲 2.76
1.395 52 週間の範囲 4.1598
時価総額
前日終値
2.69
始値
2.63
最終取引時間
財務取引量
US$ 24,622,037
VWAP
2.6641
平均取引量 (3 か月)
2,083,348
発行済株式数
336,566,525
配当利回り
-
PER
-11.86
1 株当たり利益 (EPS)
-0.23
歳入
-
純利益
-75.8M

Panacea Acquisition Corp について

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Panacea Acquisition Corp is listed in the Pharmaceutical Preparations sector of the ニューヨーク証券取引所 with ticker NUVB. The last closing price for Panacea Acquisition was US$2.69. Over the last year, Panacea Acquisition shares have traded in a share price range of US$ 1.395 to US$ 4.1598.

Panacea Acquisition currently has 336,566,525 shares in issue. The market capitalisation of Panacea Acquisition is US$905.36 million. Panacea Acquisition has a price to earnings ratio (PE ratio) of -11.86.

NUVB 最新ニュース

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration PR Newswire SAN FRANCISCO and SUZHOU, China, Dec. 20...

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

Nuvation Bio to Present at the Jefferies London Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

Submitted New Drug Application (NDA) for taletrectinib to the U.S. Food and Drug Administration (FDA) in October for the treatment of patients with advanced ROS1-positive (ROS1+) non-small cell...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.13.816793893132.622.8652.5126641072.688133CS
40.010.3690036900372.713.052.5123366292.78385554CS
120.239.236947791162.493.08220833482.60610832CS
26-0.18-6.206896551722.93.97218083862.81568788CS
521.2686.3013698631.464.15981.39515142212.78523577CS
156-5.67-67.58045292018.398.880.9510596022.80732217CS
260-7.28-72.81015.230.9510209514.28526185CS

NUVB - Frequently Asked Questions (FAQ)

What is the current Panacea Acquisition share price?
The current share price of Panacea Acquisition is US$ 2.72
How many Panacea Acquisition shares are in issue?
Panacea Acquisition has 336,566,525 shares in issue
What is the market cap of Panacea Acquisition?
The market capitalisation of Panacea Acquisition is USD 905.36M
What is the 1 year trading range for Panacea Acquisition share price?
Panacea Acquisition has traded in the range of US$ 1.395 to US$ 4.1598 during the past year
What is the PE ratio of Panacea Acquisition?
The price to earnings ratio of Panacea Acquisition is -11.86
What is the reporting currency for Panacea Acquisition?
Panacea Acquisition reports financial results in USD
What is the latest annual profit for Panacea Acquisition?
The latest annual profit of Panacea Acquisition is USD -75.8M
What is the registered address of Panacea Acquisition?
The registered address for Panacea Acquisition is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Panacea Acquisition website address?
The website address for Panacea Acquisition is ecor1cap.com
Which industry sector does Panacea Acquisition operate in?
Panacea Acquisition operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
VNCEVince Holding Corp
US$ 4.70
(69.06%)
1.06M
SRFMSurf Air Mobility Inc
US$ 3.33
(23.79%)
367.21k
BBBlackBerry Limited
US$ 3.685
(23.66%)
40.27M
ALURAllurion Technologies Inc
US$ 0.3439
(22.87%)
702.83k
CLWClearWater Paper Corporation
US$ 30.26
(22.46%)
3.5M
IIPRInnovative Industrial Properties Inc
US$ 73.50
(-22.91%)
3.15M
KUKEKuke Music Holding Limited
US$ 0.31
(-20.51%)
61.48k
NVONovo Nordisk
US$ 85.00
(-17.83%)
53.81M
CANGCango Inc
US$ 5.08
(-11.81%)
2.44M
BNEDBarnes and Noble Education Inc
US$ 9.965
(-10.31%)
1.55M
QBTSD Wave Quantum Inc
US$ 6.638
(4.21%)
124.23M
PFEPfizer Inc
US$ 26.36
(2.29%)
111.08M
APOApollo Global Management Inc
US$ 171.03
(0.83%)
94.47M
TAT&T Inc
US$ 22.75
(0.80%)
88.77M
FFord Motor Company
US$ 9.885
(1.49%)
87.61M

NUVB Discussion

投稿を表示